LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 534.78M
Enterprise Value 335.87M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)132.50
Price/Book (mrq)14.50
Enterprise Value/Revenue 3136.64
Enterprise Value/EBITDA 6-8.79

Trading Information

Stock Price History

Beta (5Y Monthly) 2.43
52-Week Change 3-67.38%
S&P500 52-Week Change 315.37%
52 Week High 31.5300
52 Week Low 30.3000
50-Day Moving Average 30.4679
200-Day Moving Average 30.5412

Share Statistics

Avg Vol (3 month) 397k
Avg Vol (10 day) 360.62k
Shares Outstanding 580.72M
Float 63.57M
% Held by Insiders 119.28%
% Held by Institutions 10.05%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 211:10
Last Split Date 3Dec. 15, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug. 30, 2019
Most Recent Quarter (mrq)Nov. 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,586.70%

Management Effectiveness

Return on Assets (ttm)-82.76%
Return on Equity (ttm)-145.33%

Income Statement

Revenue (ttm)262.48k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)179.50%
Gross Profit (ttm)192.53k
EBITDA -4.08M
Net Income Avi to Common (ttm)-4.31M
Diluted EPS (ttm)-0.0550
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.36M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.68
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-3.09M
Levered Free Cash Flow (ttm)-2.08M